Diltiazem HCL Injection (Banner Pharmacy) – Sterility Concern (2017)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Diltiazem HCL 125 mg added to 0.9% Sodium Chloride 100 ml bag, 125 mL bag, Rx Only, Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 85226, NDC 7025018601
Brand
Banner Pharmacy Services, LLC
Lot Codes / Batch Numbers
Lot #: 071817S1, Exp 10/18/2017, 072417S1, Exp 10/24/2017, 072517S1, Exp 10/25/2017, 081117S1, Exp 11/11/2017, 081517S1, Exp 11/15/2017, 082217S1, Exp 11/22/2017
Products Sold
Lot #: 071817S1, Exp 10/18/2017; 072417S1, Exp 10/24/2017; 072517S1, Exp 10/25/2017; 081117S1, Exp 11/11/2017; 081517S1, Exp 11/15/2017; 082217S1, Exp 11/22/2017
Banner Pharmacy Services, LLC is recalling Diltiazem HCL 125 mg added to 0.9% Sodium Chloride 100 ml bag, 125 mL bag, Rx Only, Banner Health Co due to Lack of Assurance of Sterility.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of Assurance of Sterility.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026